Flasks and culture chambers for many cell culture applications including stem cell, cancer, and immune system research, enabling increased scale of cell culture and improved yields
Corning has announced several new products coated with the Ultra-Low Attachment surface.
The new 25 and 75cm2 flasks and Cellstack culture chambers are well-suited for many cell culture applications including stem cell, cancer, and immune system research, and enable customers to increase the scale of cell culture, improve yields, and reduce contamination risks.
The Ultra-Low Attachment surface effectively inhibits cellular attachment and minimizes protein absorption, enzyme activation, and cellular activation.
This helps customers to reduce or eliminate cell attachment in a variety of challenging culture applications or techniques.
To date, Corning Life Sciences customers have identified a wide range of applications for the surface, including cell-based vaccines, stem cell therapies, cancer biology (research), primary cell cultivation, hybridoma (antibody production), and insect cell culture.
The Ultra-Low Attachment surface features a covalently bound hydrogel layer that is non-biological and requires no prehydration step prior to use in cell culture.
The Ultra-Low Attachment surface is well-suited for:.
Maintaining cells in a suspended, unattached state.
Preventing stem cells from attachment-mediated differentiation.
Preventing anchorage-dependent cells from dividing.
Selectively culturing tumour or virally transformed cells as unattached colonies.
Reducing binding of attachment and serum proteins to the substrate.
"Corning Life Sciences continues to directly engage with its worldwide customers in order to bring to market innovative products and technologies that make demonstrable improvements in research methodologies and practices," said Lydia Kenton, business manager, cells, Corning Life Sciences.
"These new products will enable our customers to further advance research supporting cell therapeutics and other exciting new applications of cell culture technology".
"They are a great addition to our existing portfolio of products and tangible evidence of our ongoing investments to provide novel solutions for our cell culture customers," added Ron Verkleeren, WW marketing manager, cells, Corning Life Sciences.
